RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,520 | -16.3% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $24,510 | -2.3% | 19,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $25,080 | -12.0% | 19,000 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $28,500 | +29.5% | 19,000 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $22,000 | +4.8% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $21,000 | -63.8% | 19,000 | -2.6% | 0.00% | -66.7% |
Q1 2022 | $58,000 | +13.7% | 19,504 | +0.5% | 0.00% | +50.0% |
Q4 2021 | $51,000 | -27.1% | 19,398 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $70,000 | -16.7% | 19,398 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $84,000 | +27.3% | 19,398 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $66,000 | -2.9% | 19,398 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $68,000 | +47.8% | 19,398 | +2.1% | 0.00% | +33.3% |
Q3 2020 | $46,000 | +31.4% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $35,000 | +16.7% | 19,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $30,000 | -23.1% | 19,000 | +5.6% | 0.00% | -25.0% |
Q4 2019 | $39,000 | +14.7% | 18,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $34,000 | – | 18,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |